KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Interest & Investment Income (2009 - 2026)

Abbott Laboratories recorded quarterly Interest & Investment Income of $106.0 million in Q1 2026, up 35.9% quarter-over-quarter from $78.0 million in Q4 2025, and up 29.27% year-over-year from $82.0 million in Q1 2025.

Abbott Laboratories' Interest & Investment Income history runs 18 years deep, the most recent figure standing at $106.0 million for Q1 2026.

  • In Q1 2026, Interest & Investment Income rose 29.27% year-over-year to $106.0 million; the TTM figure through Mar 2026 stood at $332.0 million (down 4.05% YoY), while the FY2025 annual figure was $308.0 million, down 10.47% from the prior year.
  • Interest & Investment Income came in at $106.0 million for Q1 2026 at Abbott Laboratories, up from $78.0 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $106.0 million in Q1 2026 to a low of $14.0 million in Q1 2022.
  • A 5-year average of $78.0 million and a median of $82.0 million in 2024 frame the typical range for Interest & Investment Income.
  • Across the five-year window, Interest & Investment Income surged 700.0% in 2022 and declined 20.79% in 2024, its largest moves.
  • Abbott Laboratories' Interest & Investment Income stood at $88.0 million in 2022, then gained by 1.14% to $89.0 million in 2023, then climbed by 2.25% to $91.0 million in 2024, then retreated by 14.29% to $78.0 million in 2025, then surged by 35.9% to $106.0 million in 2026.
  • According to Business Quant data, Interest & Investment Income over the past three periods registered $106.0 million, $78.0 million, and $77.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 106.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 33.50 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -25.76 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 106.00 Mn
Dec 31, 2025 78.00 Mn
Sep 30, 2025 77.00 Mn
Jun 30, 2025 71.00 Mn
Mar 31, 2025 82.00 Mn
Dec 31, 2024 91.00 Mn
Sep 30, 2024 91.00 Mn
Jun 30, 2024 82.00 Mn
Mar 31, 2024 80.00 Mn
Dec 31, 2023 89.00 Mn
Sep 30, 2023 97.00 Mn
Jun 30, 2023 98.00 Mn
Mar 31, 2023 101.00 Mn
Dec 31, 2022 88.00 Mn
Sep 30, 2022 55.00 Mn
Jun 30, 2022 26.00 Mn
Mar 31, 2022 14.00 Mn
Dec 31, 2021 11.00 Mn
Sep 30, 2021 10.00 Mn
Jun 30, 2021 11.00 Mn
Mar 31, 2021 11.00 Mn
Dec 31, 2020 9.00 Mn
Sep 30, 2020 10.00 Mn
Jun 30, 2020 9.00 Mn
Mar 31, 2020 18.00 Mn
Dec 31, 2019 25.00 Mn
Sep 30, 2019 24.00 Mn
Jun 30, 2019 22.00 Mn
Mar 31, 2019 23.00 Mn
Dec 31, 2018 34.00 Mn
Sep 30, 2018 22.00 Mn
Jun 30, 2018 21.00 Mn
Mar 31, 2018 28.00 Mn
Dec 31, 2017 35.00 Mn
Sep 30, 2017 36.00 Mn
Jun 30, 2017 31.00 Mn
Mar 31, 2017 22.00 Mn
Dec 31, 2016 24.00 Mn
Sep 30, 2016 22.00 Mn
Jun 30, 2016 20.00 Mn
Mar 31, 2016 33.00 Mn
Dec 31, 2015 32.00 Mn
Sep 30, 2015 25.00 Mn
Jun 30, 2015 27.00 Mn
Mar 31, 2015 21.00 Mn
Dec 31, 2014 24.00 Mn
Sep 30, 2014 18.00 Mn
Jun 30, 2014 19.00 Mn
Mar 31, 2014 16.00 Mn
Dec 31, 2013 19.00 Mn
Sep 30, 2013 16.00 Mn
Jun 30, 2013 17.00 Mn
Mar 31, 2013 15.00 Mn
Dec 31, 2012 -129.71 Mn
Sep 30, 2012 63.87 Mn
Jun 30, 2012 18.89 Mn
Mar 31, 2012 16.27 Mn
Dec 31, 2011 3.60 Mn
Sep 30, 2011 20.82 Mn
Jun 30, 2011 18.87 Mn
Mar 31, 2011 21.72 Mn
Dec 31, 2010 22.16 Mn
Sep 30, 2010 15.59 Mn
Jun 30, 2010 38.17 Mn
Mar 31, 2010 29.53 Mn
Dec 31, 2009 29.45 Mn
Sep 30, 2009 38.41 Mn
Jun 30, 2009 33.88 Mn